Drug intelligence / Profile preview

Jagged peptide

Development stage
Preclinical
Modality
Peptides
Administration
Subcutaneous, Intravenous, Intramuscular, Intraperitoneal, Intradermal, Intratumoral, Intralesional, Parenteral
01

Overview

Jagged peptide is a synthetic peptide derived from the Notch ligand Jagged (typically Jagged1), specifically mimicking the Delta/Serrate/LAG-2 (DSL) domain required for Notch receptor activation. It functions as a Notch signaling agonist. In oncological research, particularly in glioblastoma multiforme (GBM), Jagged peptide is utilized to investigate the role of the perivascular niche in maintaining cancer stem-like cells (CSLCs). By activating Notch signaling, the peptide promotes the self-renewal, expression of stemness markers like CD133, and clonogenicity of GBM cells. While primarily employed as a research tool to study juxtacrine signaling and lateral inhibition, Notch-activating peptides are also explored for potential applications in regenerative medicine and hematopoiesis.

Other names
Jagged1 peptideJagged-1 peptideJagged 1 peptideJagged-1 DSL peptideJagged1 DSL peptideJagged 1 DSL peptideNotch ligand peptide
02

Targets

NOTCH (Neurogenic locus notch homolog protein 3)

Beyond the preview

Go deeper on Jagged peptide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jagged peptide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call